Table 3.

Rates of E. coli ST131 positivity of the ESBL, non-ESBL, ciprofloxacin-nonsusceptible, ciprofloxacin-susceptible, MDR, and non-MDR groups

	ST131 positive % (number/total number)
ESBL n = 13	53.6% (7/13)
Non-ESBL n = 144	4.2% (6/144)
P	< 0.001
Ciprofloxacin non-susceptible (n = 29)	24.1% (7/29)
Ciprofloxacin susceptible (n = 128)	4.7% (6/128)
P	0.003
MDR (n = 58)	13.8% (8/58)
Non-MDR (n = 99)	5.1% (5/99)
P	0.073